3. Quiza. Selective Breedingb. Genetically modified via biotechnologyc. Nollywood
4. “African countries need to think andoperate as stakeholders, rather thanaccepting the „victim mentality‟ created inEurope.”Florence Wambugu ISAAA
5. Biotech and Yields•U.S. yields outpaceEU•Productivity+4.4%/year•GM Wheatagreement
6. Agricultural Investment • Food processing has captured just 10% of cross-border investment; • Production agriculture received just 0.0006%
7. Ag Biotechnology Investment• US$8.6 billion Venture capital investment in life sciences in 2007.• One-third of all venture capital in U.S., Canada and Sweden in life sciences.
8. Efficient Regulatory ManagementHigh cost ofregulatorycompliance is Componentsone of thereasons • National Biosafety Policydelayingrelease of • Regulatory Regime (objective)events in • Transparent Administrative systemdeveloping • Public Awareness and Participationcountries. • System for Follow-upFAO
9. 2-5 years, all new crops.Excessive regulation has its impact.
10. Publicly Supported GM Field Trials
11. Pace Grows Exponentially1,000,000,000 Single molecule? 100,000,000 Massively parallel sequencing Short-read 10,000,000 sequencers 1,000,000 Microwell Capillary pyrosequenc ing 100,000 sequencing Second- 10,000 Gel-based generation systems capillary Automated sequencer 1,000 First- Manual Slab Slab Gel generation Gel 100 capillary
12. Still Debating Last Century’s Technology Metabolic Pathway Engineering Synthetic Biology Nanotechnology Transgenics Mutagenisis CloningSelective Breeding and Hybridization
13. Biotech and Nigeria’s Future • Hunger • Health/Output TraitsPresidentYar’adua: • Disease/Insect/Herbicide ResistanceNot just food • Nitrogen Fixingsecurity butagriculture as a • Drought Resistancemajor foreignexchange • Salinity Toleranceearner by 2020. • Climate Change (both GHG reduction and adaptation) • Energy